730 related articles for article (PubMed ID: 34758391)
1. SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance.
Jian MJ; Chung HY; Chang CK; Lin JC; Yeh KM; Chen CW; Lin DY; Chang FY; Hung KS; Perng CL; Shang HS
Int J Infect Dis; 2022 Jan; 114():112-114. PubMed ID: 34758391
[TBL] [Abstract][Full Text] [Related]
2. A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance.
Bourassa L; Perchetti GA; Phung Q; Lin MJ; Mills MG; Roychoudhury P; Harmon KG; Reed JC; Greninger AL
J Clin Virol; 2021 Aug; 141():104900. PubMed ID: 34171548
[TBL] [Abstract][Full Text] [Related]
3. A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen-Based Diagnostic Tests for COVID-19.
Golden A; Cantera JL; Lillis L; Phan TT; Slater H; Webb EJ; Peck RB; Boyle DS; Domingo GJ
Microbiol Spectr; 2023 Jun; 11(3):e0373122. PubMed ID: 37166329
[TBL] [Abstract][Full Text] [Related]
4. Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests.
Tieman BC; Kovacs S; Rodgers MA; Mohaimani A; Gregory S; Christensen D; Moore JA; Schurig-Briccio L; Hartnett J; Kar A; Leeman A; Palmer A; Rogers L; Dragoo B; Muszynski S; Noblesmith D; Gardner S; Snipe-Bushey A; Kill A; Luo X; Cherukuri S; Rae T; Marohnic CC; Cloherty GA; Muerhoff AS; Hemken PM
Biotechniques; 2022 Sep; 73(3):136-141. PubMed ID: 36004516
[TBL] [Abstract][Full Text] [Related]
5. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
Troyano-Hernáez P; Reinosa R; Holguín Á
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
[TBL] [Abstract][Full Text] [Related]
6. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
[TBL] [Abstract][Full Text] [Related]
7. Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view.
Martín J; Tena N; Asuero AG
Microchem J; 2021 Aug; 167():106305. PubMed ID: 33897053
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
[TBL] [Abstract][Full Text] [Related]
9. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of SARS-CoV-2 Nucleocapsid Antigen Self-Test in Comparison to Reverse Transcriptase-Polymerase Chain Reaction.
Sukumaran A; Suvekbala V; R AK; Thomas RE; Raj A; Thomas T; Abhijith BL; Jose J; Paul JK; Vasudevan DM
J Appl Lab Med; 2022 Jun; 7(4):871-880. PubMed ID: 35689333
[TBL] [Abstract][Full Text] [Related]
11. Clinical assessment of SARS-CoV-2 antigen rapid detection compared with RT-PCR assay for emerging variants at a high-throughput community testing site in Taiwan.
Jian MJ; Perng CL; Chung HY; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Pan PC; Chang HT; Chang FY; Ho CL; Shang HS
Int J Infect Dis; 2022 Feb; 115():30-34. PubMed ID: 34843956
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of a Visually-Read Rapid Antigen Test Kit (SGA V-Chek) for Detection of SARS-CoV-2 Virus].
Kipritci Z; Keskin AÜ; Çıragil P; Topkaya AE
Mikrobiyol Bul; 2021 Jul; 55(3):461-464. PubMed ID: 34416811
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 N gene dropout and N gene Ct value shift as indicator for the presence of B.1.1.7 lineage in a commercial multiplex PCR assay.
Wollschläger P; Todt D; Gerlitz N; Pfaender S; Bollinger T; Sing A; Dangel A; Ackermann N; Korn K; Ensser A; Steinmann E; Buhl M; Steinmann J
Clin Microbiol Infect; 2021 Sep; 27(9):1353.e1-1353.e5. PubMed ID: 34044153
[TBL] [Abstract][Full Text] [Related]
14. Comparison of five SARS-CoV-2 rapid antigen detection tests in a hospital setting and performance of one antigen assay in routine practice: a useful tool to guide isolation precautions?
Van Honacker E; Van Vaerenbergh K; Boel A; De Beenhouwer H; Leroux-Roels I; Cattoir L
J Hosp Infect; 2021 Aug; 114():144-152. PubMed ID: 33785377
[TBL] [Abstract][Full Text] [Related]
15. Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021.
Trobajo-Sanmartín C; Miqueleiz A; Portillo ME; Fernández-Huerta M; Navascués A; Sola Sara P; López Moreno P; Ordoñez GR; Castilla J; Ezpeleta C
J Clin Microbiol; 2021 Nov; 59(12):e0173621. PubMed ID: 34495709
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of SARS-CoV-2 nucleocapsid protein mutations identified in Turkey by using in silico approaches.
Akcesme B; Erkal B; Donmez ZY
Acta Virol; 2023; 67(1):59-68. PubMed ID: 36950886
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants.
van Ogtrop ML; van de Laar TJW; Eggink D; Vanhommerig JW; van der Reijden WA
Microbiol Spectr; 2021 Dec; 9(3):e0088421. PubMed ID: 34817226
[TBL] [Abstract][Full Text] [Related]
18. Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2.
Wu H; Xing N; Meng K; Fu B; Xue W; Dong P; Tang W; Xiao Y; Liu G; Luo H; Zhu W; Lin X; Meng G; Zhu Z
Cell Host Microbe; 2021 Dec; 29(12):1788-1801.e6. PubMed ID: 34822776
[TBL] [Abstract][Full Text] [Related]
19. Inactivation and Recovery of High Quality RNA From Positive SARS-CoV-2 Rapid Antigen Tests Suitable for Whole Virus Genome Sequencing.
Macori G; Russell T; Barry G; McCarthy SC; Koolman L; Wall P; Sammin D; Mulcahy G; Fanning S
Front Public Health; 2022; 10():863862. PubMed ID: 35592078
[TBL] [Abstract][Full Text] [Related]
20. Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.
Ghosh AK; Kaiser M; Molla MMA; Nafisa T; Yeasmin M; Ratul RH; Sharif MM; Akram A; Hosen N; Mamunur R; Amin MR; Islam A; Hoque ME; Landt O; Lytton SD
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
